Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | NPC1 | O15118 | 4/20 | 0.61 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | KIF11 | P52732 | 1/20 | 0.57 |
| ▸ | TGM2 | P21980 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | NMT1 | P30419 | 1/20 | 0.53 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11461040 | 0.87 | SMN1; SMN2 (0.48) | TDP1POLBNPC1RAB9AKDM4E | |
| SCHEMBL1275920 | 0.82 | ALDH1A1 (0.70) | TDP1POLBNPC1RAB9AKDM4E | |
| SCHEMBL455439 | 0.82 | TDP1 (0.70) | TDP1POLBNPC1RAB9AKIF11 | |
| SCHEMBL6850999 | 0.82 | KDM4E (0.79) | TDP1POLBNPC1RAB9AKIF11 | |
| SCHEMBL27177335 | 0.80 | ALDH1A1 (0.46) | TDP1POLBNPC1RAB9AKDM4E | |
| Fluoride SCHEMBL11790965 | 0.80 | TDP1 (0.67) | TDP1POLBNPC1RAB9AKIF11 | |
| SCHEMBL61417 | 0.80 | TDP1 (1.00) | TDP1POLBNPC1RAB9AKDM4E | |
| SCHEMBL81433 | 0.78 | KIF11 (0.88) | TDP1POLBNPC1RAB9AKIF11 | |
| SCHEMBL5932492 | 0.78 | TDP1 (0.64) | TDP1POLBNPC1RAB9AKIF11 | |
| SCHEMBL11790956 | 0.78 | TDP1 (0.64) | TDP1POLBNPC1RAB9AKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050096406-A1 | Reactive diluents and alkyd resin coating compositions | PRETOT ROGER (CH) | 2005-05-05 | — | — | US | claimed |
| EP-1480940-A2 | REACTIVE DILUENTS AND ALKYD RESIN COATING COMPOSITIONS | Ciba SC Holding AG (CH) | 2004-12-01 | — | — | EP | claimed |
| WO-2003074466-A2 | REACTIVE DILUENTS AND ALKYD RESIN COATING COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-09-12 | — | — | WO | claimed |
| US-5238909-A | For preemergence or postemergence use | EASTMAN KODAK COMPANY (US) | 1993-08-24 | — | — | US | claimed |
| EP-0476760-A2 | 4-substituted isoxazole herbicides | EASTMAN KODAK COMPANY (US) | 1992-03-25 | — | — | EP | claimed |
| US-4154577-A | Uniformly disperse dyed water-swellable cellulosic fibers | BASF AKTIENGESELLSCHAFT (DE) | 1979-05-15 | — | — | US | claimed |
| US-4150943-A | Uniformly dyed water-swellable cellulosic fibers | BASF AKTIENGESELLSCHAFT (DE) | 1979-04-24 | — | — | US | claimed |
| CN-118239868-A | Carbamate substituted styryl sulfone compound and preparation method and application thereof | 华夏生生药业(北京)有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | MITSUI CHEMICALS, INC. (JP) | 2006-04-27 | — | — | US | disclosed |
| US-4191574-A | AZO-METHINE DYES | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1980-03-04 | — | — | US | disclosed |
| US-4157893-A | MONO OR DISAZO DYE CONTAINING AN AMINO-SUBSTITUTED PYRIMIDINE RING | BASF AKTIENGESELLSCHAFT (DE) | 1979-06-12 | — | — | US | disclosed |
| US-4154577-A | Uniformly disperse dyed water-swellable cellulosic fibers | BASF AKTIENGESELLSCHAFT (DE) | 1979-05-15 | — | — | US | disclosed |
| US-4150943-A | Uniformly dyed water-swellable cellulosic fibers | BASF AKTIENGESELLSCHAFT (DE) | 1979-04-24 | — | — | US | disclosed |
| US-4146535-A | Azo dyes having a 3-cyano- or 3-carbamoyl-2,6-diamino-pyridine coupling component | BASF AKTIENGESELLSCHAFT (DE) | 1979-03-27 | — | — | US | disclosed |
| US-4143166-A | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-03-06 | — | — | US | disclosed |
| US-4138264-A | Silver halide emulsion containing two equivalent type coupler for use in photography | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1979-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | ALPG, TRPC6, GNRHR | TDP1 316/4885POLB 1763/4885NPC1 4636/4885 |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | TDP1 4548/4885POLB 757/4885NPC1 3130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.